Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/27/2015 08/28/2015 08/31/2015 09/01/2015 09/02/2015 Date
6.98(c) 9.89(c) 9.44(c) 9.095(c) 7.55(c) Last
3 716 317 38 733 030 13 489 561 7 015 833 14 348 907 Volume
+4.33% +41.69% -4.55% -3.65% -16.99% Change
More quotes
Financials ($)
Sales 2015 156 M
EBIT 2015 -201 M
Net income 2015 -211 M
Finance 2015 38,6 M
Yield 2015 -
Sales 2016 220 M
EBIT 2016 -177 M
Net income 2016 -180 M
Debt 2016 12,6 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 8,92x
EV / Sales 2016 6,54x
Capitalization 1 426 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products includes Iclusig (ponatinib), Brigatinib (previously known as AP26113), and AP32788.The company was founded... 
Sector
Pharmaceuticals
Calendar
11/04Earnings Release
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
08/28DJBaxalta in Talks to Buy Ariad -Bloomberg
08/21 ARIAD PHARMACEUTICALS : Entry into a Material Definitive Agreement (form 8-K)
08/20 ARIAD PHARMACEUTICALS : Announces First Patient Treated in Phase 2 Dose-Ranging ..
08/14 ARIAD PHARMACEUTICALS : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an In..
08/14 ARIAD PHARMACEUTICALS : First Patient Treated in Phase 2 Dose-Ranging Optic Tria..
08/10 ARIAD PHARMACEUTICALS : Announces First Patient Treated in Phase 2 Dose-Ranging ..
08/05 ARIAD PHARMACEUTICALS : to Receive up to $200 Million Through Iclusig Non-Diluti..
08/05 PDL BIOPHARMA : Completes Royalty Transaction with ARIAD Pharmaceuticals
More news
Sector news : Biopharmaceuticals
08:31a BIOGEN : Neurocrine Biosciences Announces the Appointment of Dr. Alfred W. Sandr..
08:10aDJEUROPE MARKETS : European Markets Rise; Investors Wait For QE Hints From Draghi
07:37a NOVO NORDISK A/S : Packaging company might expand
More sector news : Biopharmaceuticals
News from SeekingAlpha
07:42a ACTIVIST INVESTING DAILY : The Tom Sandell Show?
09/02 M&A DAILY : GE & The Beer Fridge
09/02 The Defensive Anti-Chain Engulfs Ariad
09/02 Midday Gainers / Losers
09/02 ARIAD Pharma down 19% on reports of Baxalta withdrawal


Comments 
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends ARIAD PHARMACEUTI...
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions